These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15756704)

  • 1. Relationship between renal anemia and prognostic stages of IgA nephropathy.
    Aruga S; Horiuchi T; Shou I; Tashiro K; Kurusu A; Fukui M; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2005; 19(2):80-3. PubMed ID: 15756704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy.
    Tomino Y; Suzuki S; Gohda T; Kobayashi M; Horikoshi S; Imai H; Saito T; Kawamura T; Yorioka N; Harada T; Yasumoto Y; Kida H; Kobayashi Y; Endoh M; Sato H; Saito K
    J Clin Lab Anal; 2001; 15(1):25-9. PubMed ID: 11170230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version.
    Tomino Y; Sakai H;
    Clin Exp Nephrol; 2003 Jun; 7(2):93-7. PubMed ID: 14586726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy.
    Io H; Hamada C; Fukui M; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2004; 18(1):14-8. PubMed ID: 14730552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Committee of IgA Nephropathy--the Special Study Group of Progressive Glomerular Disease, the Ministry of Health, Labor and Welfare of Japan].
    Tomino Y;
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):487-93. PubMed ID: 12476585
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum uric acid and renal prognosis in patients with IgA nephropathy.
    Ohno I; Hosoya T; Gomi H; Ichida K; Okabe H; Hikita M
    Nephron; 2001 Apr; 87(4):333-9. PubMed ID: 11287777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.
    Haas M
    Am J Kidney Dis; 1997 Jun; 29(6):829-42. PubMed ID: 9186068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.
    Koyama A; Igarashi M; Kobayashi M
    Am J Kidney Dis; 1997 Apr; 29(4):526-32. PubMed ID: 9100040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy.
    Maeda A; Gohda T; Funabiki K; Horikoshi S; Shirato I; Tomino Y
    J Clin Lab Anal; 2003; 17(3):73-6. PubMed ID: 12696075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological characteristics and prognosis of IgA nephropathy patients with microalbuminuria and deposition of complement C3].
    Guo ZY; Zhou SG; Wang YY; Li X; Xu Y; Du XY; Zhang W; Wu YM
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(9):707-11. PubMed ID: 27055509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
    Cheng GY; Liu DW; Zhang N; Tang L; Zhao ZZ; Liu ZS
    Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
    Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship among the characteristics of anemia, serum level of erythropoietin and the renal tubulointerstitial injury in drug-associated renal parenchymal acute renal failure patients].
    Zhang YJ; Li XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):471-5. PubMed ID: 16224515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
    Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S;
    Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK; Chen ML
    Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte injury predicts prognosis in patients with iga nephropathy using a small amount of renal biopsy tissue.
    Hishiki T; Shirato I; Takahashi Y; Funabiki K; Horikoshi S; Tomino Y
    Kidney Blood Press Res; 2001; 24(2):99-104. PubMed ID: 11435741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.